MarketMoodz
Intel slides 6% on soft Q1 outlook amid AI demand concerns
Intel posted a softer Q1 2026 outlook after beating Q4 2025 on earnings, sending shares down in after-hours trading. The guidance for revenue of $11.7 billion to $12.7 billion and breakeven adjusted earnings per share signals near-term headwinds for AI compute demand and ongoing supply constraints.
Key Takeaways
- Q4 2025 adjusted EPS of $0.15 and revenue of $13.7 billion beat expectations of $0.08 and $13.4 billion.
- Q4 2025 GAAP net loss of $0.12 per share on $0.6 billion, vs. a $0.01 loss a year earlier.
- Q1 2026 guidance implies revenue of $11.7B-$12.7B with breakeven EPS; shares fell as much as 6% after hours.
- Foundry revenue of $4.5B; Data Center & AI revenue $4.7B up 9%; Client Computing Group $8.2B down 7%.
- A CNBC summary claimed Intel completed a $5B stock sale to Nvidia; claim is unverified.
People Involved
- Lip-Bu TanCadence Design Systems CEO
- David ZinsnerIntel Chief Financial Officer
Entities Involved
- Intel Corp (INTC)Semiconductor company
- NVIDIAAI compute leader
- AMDChip designer
MarketMoodz Analysis
The soft Q1 guidance underscores the volatility of the AI compute cycle despite robust AI demand narratives. Investors should watch Intel’s capacity to convert foundry demand into sustainable revenue growth and whether 14A expansion plans materialize in H2 2026.
From a historical lens, Intel’s results reflect the broader industry shift toward AI infrastructure spending and the challenge of supply constraints in a cyclical semiconductor market. The stock reaction in after-hours trading mirrors the market’s focus on near-term visibility rather than long-run AI secular growth.
Next, investors should monitor Intel’s execution on 14A-related capex, progress in ramping foundry operations, and competitor tempo from AMD and NVIDIA, which will shape the timing of any rebound in Intel’s share price.
Source: Original Article
Get AI-Powered Market Insights
Stay ahead of market-moving events with our real-time analysis and stock ratings.
Start Your Free Trial